DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
DMCC Speciality Chemicals' board (meeting held May 5, 2025; re-filed in machine-readable form on May 14, 2025 at NSE's request) approved audited standalone and consolidated results for Q4 and FY ended March 31, 2025, carrying an unmodified auditor's opinion. For FY25, standalone net sales rose to about Rs. 380.43 crore from Rs. 327.82 crore in FY24, while net profit nearly doubled to Rs. 21.51 crore (EPS Rs. 8.64) from Rs. 11.57 crore (EPS Rs. 4.54). In Q4 FY25 alone, net sales were Rs. 12.52 crore vs Rs. 8.30 crore in Q4 FY24, with net profit of Rs. 6.47 crore vs Rs. 5.78 crore. The board recommended a 25% final dividend (Rs. 2.50 per share on Rs. 10 face value), subject to shareholder approval, and fixed the 104th AGM for September 10, 2025 via video conferencing. It also appointed Shri Satish Kumar Jain as secretarial auditor for five years (FY26–FY30) and re-appointed Shri S. S. Dongare as cost auditor for FY26.
The sharp jump in full-year profit and a 25% final dividend are shareholder-friendly signals, but investors should note FY24 profit was inflated by a one-time Rs. 8.44 crore gain from sale of unlisted equity investments and that a Dahej plant maintenance shutdown in late Dec 2024 to early Jan 2025 may have weighed on Q3 numbers—underlying growth is still healthy, just not as dramatic as the headline suggests.